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Introduction
Personalized medicine or precision medicine has been an emerging
market for better treatments of patients under varying physiological
conditions. To improve the on growing development of personalized
medicine, a higher understanding of drug-protein binding between serum
transport proteins and the unbound form of pharmaceuticals is needed.
Human Serum Albumin (HSA) and Alpha1-acid glycoprotein (AGP)
play a crucial role in pharmacokinetics as they are two most abundant
transport serum proteins in body circulatory system. Inter-individual
variabilities of serum proteins, such as the physiological condition of
patients, have been believed to alter the drug-serum protein binding.
Fig.1 shows an example of the cause of inter-individual variabilities of
AGP by various degree of glycans.
Figure 1. Five carbohydrate glycosylation sites of AGP
Hydroxychloroquine (HCQ) is an antimalarial drug and has been used
to treat rheumatic disease such as rheumatoid arthritis (RA) and systemic
lupus erythematosus (SLE) due to its immunomodulatory effects for
rheumatic diseases.
Figure 2. Structure of Hydroxychloroquine
In this study, a lectin affinity chromatography, a zonal elution, and
ultrafast affinity extraction were performed to investigate
hydroxychloroquine-serum protein interactions.
METHODS
Lectin Affinity Chromatography
• Concanavalin A (Con A) can bind to complex type biantennary glycans 
(weak to moderate binding). A Con A immobilized  column can be 
used to separate AGP with biantennary glycans from normal AGP. 
Protein Immobilization
• Entrapment vs Schiff-base method
Figure 3. Entrapped serum protein by using mildly oxidized glycogen 
Zonal Elution
• Retention factor analysis – determination of solute-protein interaction
Ultrafast Affinity Extraction
• Rapid extraction of free drug fractions by using affinity microcolumn
Figure 4. General scheme for ultrafast affinity extraction
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GOAL OF STUDY
Investigate hydroxychloroquine-serum protein interaction
through HSA and AGP glycoforms immobilized affinity
microcolumns.
RESULTS
Lectin Affinity Chromatography
Figure 5. AGP fractions separation by Con A lectin affinity chromatography 
Zonal Elution
Figure 6. Comparison of retention factors of hydroxychloroquine
Ultrafast Affinity Extraction
• N I H  R 0 1  D K 0 6 9 6 2 9
• S. Beeram, X. Zheng, K. Suh, D. S. Hage, Characterization of solution-phase drug-protein interactions 
by ultrafast affinity extraction. A review, Methods, 146 (2018), 46-57.
• T. Fournier, N. Medjoubi-N, D. Porquet, Biochim. Biophys. Acta. 1482 (2000) 157-171
• I. Ben-Zvi, S. Kivity, P. Langevitz, Y. Shoenfeld, Hydroxychloroquine: from malaria to autoimmunity. Clin 
Rev Allergy Immunol. 2012;42(2):145–153. 
HSA AGP
Free Fraction nKa(M-1) Free Fraction nKa(M-1)
63% 1.65(±0.10)X104 84% 1.02(±0.16)X104
Conclusion
This study examined the interaction between
hydroxychloroquine and serum proteins, HSA and AGP. AGP
fractions with bi-antennary glycans and tri- tetra-antennary were
separated by lectin affinity chromatography using Concanavalin A
and were used for affinity microcolumns. Entrapment of serum
proteins can result in the use of intact serum proteins.
Zonal elution results indicated the different contribution of the
different glycoforms of AGP onto hydroxychloroquine binding.
Ultrafast affinity extraction provided a relatively fast and precise
binding information of hydroxychloroquine to serum proteins. The
information obtained by this study can provide a better
understanding for estimating hydroxychloroquine-serum protein
interactions.
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Retention Factor Comparision
k’ : Retention factor
Ka : Association equilibrium   
constant
mL : Protein content
VM : Column void volume
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